// App-Quantinova.ai

: Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD

Researchers

Presenter

  • Jaco Voorham

Principal Investigators

  • Marjan Kerkhof

  • Mario Scuri

  • Stefano Vezzoli

  • Ilaria Valente

  • Alberto Papi

  • Claus Vogelmeier

  • David Singh

  • Leonardo Fabbri

  • Janwillem Kocks

  • David Price

Medical Centers

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • Chiesi Farmaceutici, S.p.A, Parma, Italy,

  • Respiratory Medicine, University of Ferrara, Ferrara, Italy,

  • Department of Medicine (Pulmonary and Critical Care Medicine), University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, Germany,

  • Medicines Evaluation Unit, National Institute for Health Research Respiratory and Allergy Clinical Research Facility, University Hospital of South Manchester NHS Foundation Trust, University of Manchester, Manchester, United Kingdom

  • Department of Oncology, Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy

Locations

  • Singapore

  • Italy

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved